SAN DIEGO, CA, Global biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, has raised $45M. Read More
NEW YORK, NY, Artificial intelligence company connecting the world's patients to better treatments and improved health, has closed a Series A fundraising round with $12.25M. Read More